KBC Group NV raised its holdings in shares of Ingevity Co. (NYSE:NGVT – Free Report) by 27.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,007 shares of the company’s stock after purchasing an additional 433 shares during the period. KBC Group NV’s holdings in Ingevity were worth $82,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of the business. Vestcor Inc acquired a new stake in shares of Ingevity in the third quarter valued at approximately $796,000. Geode Capital Management LLC increased its position in Ingevity by 4.3% in the 3rd quarter. Geode Capital Management LLC now owns 815,661 shares of the company’s stock valued at $31,817,000 after acquiring an additional 33,973 shares during the period. JPMorgan Chase & Co. raised its stake in Ingevity by 24.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 117,581 shares of the company’s stock valued at $4,586,000 after acquiring an additional 23,460 shares in the last quarter. Hennion & Walsh Asset Management Inc. acquired a new position in Ingevity during the 4th quarter worth $239,000. Finally, Mitsubishi UFJ Asset Management UK Ltd. bought a new position in shares of Ingevity in the fourth quarter worth $530,000. 91.59% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Separately, BMO Capital Markets upped their price objective on shares of Ingevity from $40.00 to $47.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Ingevity currently has a consensus rating of “Moderate Buy” and a consensus price target of $52.17.
Ingevity Stock Down 2.7 %
NYSE NGVT opened at $42.59 on Monday. The company has a debt-to-equity ratio of 6.52, a current ratio of 1.76 and a quick ratio of 1.04. The company has a market capitalization of $1.55 billion, a P/E ratio of -2.74 and a beta of 1.64. The company’s 50 day simple moving average is $43.64 and its 200 day simple moving average is $40.91. Ingevity Co. has a 12 month low of $30.90 and a 12 month high of $56.29.
Ingevity Profile
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Featured Stories
- Five stocks we like better than Ingevity
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Volatility ETFs to Help You Profit from Market Chaos
- The 3 Best Fintech Stocks to Buy Now
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- Election Stocks: How Elections Affect the Stock Market
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.